TDG Transdigm Group Incorporated reports slight Q1 2026 EPS beat and 112 percent YoY revenue growth but shares fall 169 percent Middleby MIDD Stock Factory Orders Underperforming 20260415 Why Vista VIST financial health is stronger than most think Trades Lower 20260507 OCUL Ocular Therapeutix Inc reports narrower Q4 2025 loss than consensus estimates driving a 1084 percent oneday share rally JPMorgan ChaseLed Bank Group Tightens Credit Line to Troubled KKR Private Credit Fund as Losses Mount ASML and Tata Electronics Forge Landmark Deal for Indias First Commercial Chip Fabrication Plant Europes Household Energy Prices Diverge Gas Surges Electricity Drops Amid Iran Conflict TrumpXi Summit Two Tech Flashpoints That Could Define the Outcome Kimi Antonelli Secures Historic Fourth Consecutive F1 Win in Canada Championship Standings Shift Wilson Sonsini Advises Greenhouse on Acquisition of Ezra AI Labs UK Hottest Day of Year Boosts Travel Sectors Amid Bank Holiday Queues Berkshire Hathaway Rebuilds Airline Position with 26 Billion Delta Air Lines Stake Dropbox CEO Drew Houston Steps Down After 19 Years Transitions to Executive Chairman Meta Tests AI Subscription Plans Starting at 799 Monthly urbangro Inc UGRO Q3 2025 Earnings Staggering Loss Shocks Market Amid Missing Revenue Data SAIC Q1 2026 Earnings Strong EPS Surprise Drives Stock Higher MFA Financial Inc 8875 Senior Notes due 2029 MFAN Q1 2026 Earnings Slight EPS Miss Amid Stable Bond Performance Main Street Capital Corporation MAIN Q1 2026 Earnings EPS Miss Weighs on Shares Polar Power Inc POLA Q1 2026 Earnings Net Loss of 005 Per Share Shares Fall 57 Amid Thin Disclosure Concentra Group Holdings CON Q1 2026 Earnings EPS Beats Estimates by 17 Stock Slips Despite Profit Surprise AO Smith AOS Rises 183 as Shares Approach Key Resistance Ryan Specialty Holdings RYAN Gains Momentum as Shares Approach Resistance AbCellera Biologics ABCL Bounces from Support Biotech Stock Gains 173 on Renewed Interest Xtant Medical Holdings XTNT Gains 208 as Stock Approaches Key Resistance at 050 ARS Pharmaceuticals SPRY Gains Ground Testing Resistance at 893 After 4 Rally US Equity Funds See Outflows as Investors Eye Higher Bond Yields AIRG Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Criteo CRTO Surges 46 Breaking Above Key Resistance Levels